TALPHERA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.03 USD | -0.96% |
|
-4.63% | +40.14% |
| 05-14 | Transcript : Talphera, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | Talphera, Inc. Appoints Dr. Shakil Aslam as Chief Development Officer, Effective May 20, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TALPHERA, INC. | Specialty & Advanced Pharmaceuticals | -0.96% | -4.63% | +40.14% | +17.05% | -98.12% | 17.67M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- TLPH Stock
- Charts Talphera, Inc.
- Comparison Chart
